Attorney General John Ashcroft declared on Nov. 9, 2001 that promoting suicide is not a "legitimate medical purpose" under the Controlled Substance Act (CSA), the federal law regulating doctors' ability to prescribe controlled drugs. He directed that federally controlled substances may not be used to assist suicide.
Under his order, published in the Federal Register, physicians who prescribe, dispense or administer federally controlled substances to assist suicide would face possible suspension or revocation of their federal drug registration. Ashcroft's directive relied on precedents establishing the Justice Department's power to prosecute doctors for pushing drugs.
Ashcroft's interpretation of the CSA was similar to that of the Clinton-appointed head of the Drug Enforcement Agency, Thomas Constantine. In 1997, Constantine wrote to Rep. Henry Hyde that "delivering, dispensing or prescribing a controlled substance with the intent of assisting a suicide would not be under any current definition a 'legitimate medical purpose.'"
But there is intense political and financial pressure in favor of physician-assisted suicide, first popularized by Dr. Jack Kevorkian. In late 1997, a new Oregon law authorized physician-assisted suicide, and Attorney General Janet Reno declared that "the federal government's pursuit of adverse actions against Oregon physicians who fully comply with that state's Death with Dignity Act would be beyond the purpose of the CSA."
Ashcroft, of course, is not bound by Reno's policy decisions, just as Reno was not bound by her predecessors' policies. The reason many voted for George W. Bush was to change executive policies, including those at the Department of Justice.
But suicide activists in Oregon found a Clinton-appointed judge to invalidate Ashcroft's directive. In the case called Oregon v. Ashcroft, 2002 U.S. Dist. LEXIS 6695 (D. Or. Apr. 17, 2002), the judge ruled that no provision of the CSA specifically addresses the issue of "whether physician-assisted suicide constitutes a legitimate medical purpose or practice," and concluded that this omission deprived Ashcroft of authority for his directive.
The judge admitted that "under the CSA, the Attorney General and the DEA have broad authority to regulate controlled substances," but asserted that this statutory mandate does not grant them the power to "define what constitutes legitimate medical practices," a matter within state jurisdiction.
The judge couched his opinion in conservative doctrines of federal skepticism toward legislative history, and limitations on delegation to agencies. He declared that the government had abandoned the argument in Justice Clarence Thomas's unanimous judgment affirming federal limitations on state laws legalizing the medical use of marijuana. United States v. Oakland Cannabis Buyers' Coop., 532 U.S. 483 (2001).